| DRAM, a p53-induced modulator of autophagy, is critical for apoptosis D Crighton, S Wilkinson, J O'Prey, N Syed, P Smith, PR Harrison, ... Cell 126 (1), 121-134, 2006 | 1654 | 2006 |
| Detecting psychological distress in cancer patients: validity of the Italian version of the Hospital Anxiety and Depression Scale M Costantini, M Musso, P Viterbori, F Bonci, L Del Mastro, O Garrone, ... Supportive Care in Cancer 7, 121-127, 1999 | 611 | 1999 |
| Effect of the gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapy-induced early menopause in premenopausal women with breast cancer: a … L Del Mastro, L Boni, A Michelotti, T Gamucci, N Olmeo, S Gori, ... Jama 306 (3), 269-276, 2011 | 469 | 2011 |
| Topical dimethylsulfoxide for the prevention of soft tissue injury after extravasation of vesicant cytotoxic drugs: a prospective clinical study. G Bertelli, A Gozza, GB Forno, MG Vidili, S Silvestro, M Venturini, ... Journal of Clinical Oncology 13 (11), 2851-2855, 1995 | 280 | 1995 |
| Identification of CDK10 as an important determinant of resistance to endocrine therapy for breast cancer E Iorns, NC Turner, R Elliott, N Syed, O Garrone, M Gasco, ANJ Tutt, ... Cancer cell 13 (2), 91-104, 2008 | 255 | 2008 |
| Prospective evaluation of major vascular events in patients with nonsmall cell lung carcinoma treated with cisplatin and gemcitabine G Numico, O Garrone, V Dongiovanni, N Silvestris, I Colantonio, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2005 | 249 | 2005 |
| Ovarian suppression with triptorelin during adjuvant breast cancer chemotherapy and long-term ovarian function, pregnancies, and disease-free survival: a randomized clinical trial M Lambertini, L Boni, A Michelotti, T Gamucci, T Scotto, S Gori, ... Jama 314 (24), 2632-2640, 2015 | 235 | 2015 |
| Multicenter randomized controlled clinical trial to evaluate cardioprotection of dexrazoxane versus no cardioprotection in women receiving epirubicin chemotherapy for advanced … M Venturini, A Michelotti, L Del Mastro, L Gallo, F Carnino, O Garrone, ... Journal of Clinical Oncology 14 (12), 3112-3120, 1996 | 224 | 1996 |
| Fluorouracil and dose-dense chemotherapy in adjuvant treatment of patients with early-stage breast cancer: an open-label, 2× 2 factorial, randomised phase 3 trial L Del Mastro, S De Placido, P Bruzzi, M De Laurentiis, C Boni, ... The Lancet 385 (9980), 1863-1872, 2015 | 209 | 2015 |
| Cardiotoxicity after anthracycline chemotherapy in breast carcinoma: effects on left ventricular ejection fraction, troponin I and brain natriuretic peptide M Feola, O Garrone, M Occelli, A Francini, A Biggi, G Visconti, F Albrile, ... International journal of cardiology 148 (2), 194-198, 2011 | 196 | 2011 |
| Randomized phase III trial evaluating the role of erythropoietin in the prevention of chemotherapy-induced anemia. L Del Mastro, M Venturini, R Lionetto, O Garrone, G Melioli, W Pasquetti, ... Journal of clinical oncology 15 (7), 2715-2721, 1997 | 163 | 1997 |
| The role of pneumatic compression in the treatment of postmastectomy lymphedema. A randomized phase III study D Dini, L Del Mastro, A Gozza, R Lionetto, O Garrone, G Forno, G Vidili, ... Annals of Oncology 9 (2), 187-190, 1998 | 159 | 1998 |
| Predicting mood disorders in breast cancer patients G Morasso, M Costantini, P Viterbori, F Bonci, L Del Mastro, M Musso, ... European Journal of Cancer 37 (2), 216-223, 2001 | 145 | 2001 |
| Nine weeks versus 1 year adjuvant trastuzumab in combination with chemotherapy: final results of the phase III randomized Short-HER study P Conte, A Frassoldati, G Bisagni, AA Brandes, M Donadio, O Garrone, ... Annals of Oncology 29 (12), 2328-2333, 2018 | 144 | 2018 |
| Sequential treatment with exemestane and non-steroidal aromatase inhibitors in advanced breast cancer G Bertelli, O Garrone, M Merlano, M Occelli, L Bertolotti, F Castiglione, ... Oncology 69 (6), 471-477, 2006 | 116 | 2006 |
| Tamoxifen and the endometrium: findings of pelvic ultrasound examination G Bertelli, M Venturini, LD Mastro, O Garrone, M Cosso, C Gustavino, ... Breast cancer research and treatment 47, 41-46, 1998 | 101 | 1998 |
| Cisplatin-based chemoradiation plus cetuximab in locally advanced head and neck cancer: a phase II clinical study M Merlano, E Russi, M Benasso, R Corvò, I Colantonio, R Vigna-Taglianti, ... Annals of Oncology 22 (3), 712-717, 2011 | 88 | 2011 |
| Association of tumor-infiltrating lymphocytes with distant disease-free survival in the ShortHER randomized adjuvant trial for patients with early HER2+ breast cancer MV Dieci, P Conte, G Bisagni, AA Brandes, A Frassoldati, L Cavanna, ... Annals of Oncology 30 (3), 418-423, 2019 | 87 | 2019 |
| Epigenetic inactivation implies independent functions for insulin-like growth factor binding protein (IGFBP)-related protein 1 and the related IGFBPL1 in inhibiting breast … P Smith, LJ Nicholson, N Syed, A Payne, L Hiller, O Garrone, M Occelli, ... Clinical cancer research 13 (14), 4061-4068, 2007 | 83 | 2007 |
| Comparative effects of paclitaxel and docetaxel on the metabolism and pharmacokinetics of epirubicin in breast cancer patients M Esposito, M Venturini, MO Vannozzi, G Tolino, G Lunardi, O Garrone, ... Journal of clinical oncology 17 (4), 1132-1132, 1999 | 75 | 1999 |
